Variation in prostate cancer treatment associated with population density of the county of residence. Read more about Variation in prostate cancer treatment associated with population density of the county of residence.
Predicting bone scan positivity in non-metastatic castration-resistant prostate cancer. Read more about Predicting bone scan positivity in non-metastatic castration-resistant prostate cancer.
High-throughput transcriptomic analysis nominates proteasomal genes as age-specific biomarkers and therapeutic targets in prostate cancer. Read more about High-throughput transcriptomic analysis nominates proteasomal genes as age-specific biomarkers and therapeutic targets in prostate cancer.
Nationally representative trends and geographic variation in treatment of localized prostate cancer: the Urologic Diseases in America project. Read more about Nationally representative trends and geographic variation in treatment of localized prostate cancer: the Urologic Diseases in America project.
Inhibition of the androgen receptor by mineralocorticoids at levels physiologically achieved in serum in patients treated with abiraterone acetate. Read more about Inhibition of the androgen receptor by mineralocorticoids at levels physiologically achieved in serum in patients treated with abiraterone acetate.
Time to disease-related pain and first opioid use in patients with metastatic castration-resistant prostate cancer treated with sipuleucel-T. Read more about Time to disease-related pain and first opioid use in patients with metastatic castration-resistant prostate cancer treated with sipuleucel-T.
Updated trends in imaging use in men diagnosed with prostate cancer. Read more about Updated trends in imaging use in men diagnosed with prostate cancer.
A risk-adjusted definition of biochemical recurrence after radical prostatectomy. Read more about A risk-adjusted definition of biochemical recurrence after radical prostatectomy.
Predicting bone scan positivity after biochemical recurrence following radical prostatectomy in both hormone-naive men and patients receiving androgen-deprivation therapy: results from the SEARCH database. Read more about Predicting bone scan positivity after biochemical recurrence following radical prostatectomy in both hormone-naive men and patients receiving androgen-deprivation therapy: results from the SEARCH database.
A genomic classifier predicting metastatic disease progression in men with biochemical recurrence after prostatectomy. Read more about A genomic classifier predicting metastatic disease progression in men with biochemical recurrence after prostatectomy.
